Medinox
San diego-based pharmaceutical company
About Medinox
Established in 2004 in Johannesburg, South Africa, Medinox has transitioned from a local enterprise into a global entity with a significant footprint in the health and wellness sector. The company's expansion is marked by the establishment of international offices in the United Kingdom, Ireland, and Australia, facilitating the distribution of its products to 29 countries. A key figure in the company's structure is Micheal Labuschagne, who serves as the Managing Director of Medinox (Pty) Ltd. His background in the automotive, medical, and manufacturing industries informs his leadership in driving operational excellence and financial profitability. Another key individual is Gordon John Matheson, a director of Medinox (London) Limited.
Medinox operates as a manufacturer and distributor of a diverse portfolio of over-the-counter health, wellness, and consumer products. The company's business model is multifaceted, encompassing the development and distribution of its own proprietary brands, such as mx Health, VitaPlus, and thermX, as well as offering private label development services for retail clients. This end-to-end solution for private label brands covers the entire process from concept and sourcing to branding, regulatory compliance, and manufacturing oversight. Revenue is generated through the sale of its branded products and by providing these comprehensive services to retail partners, wholesalers, and pharmacies. Medinox's clientele includes major publicly traded retailers, pharmacies, and healthcare providers.
The company's product offerings are extensive, covering categories such as diagnostics, hygiene, mobility, wound care, and sports rehabilitation. Medinox provides a wide array of items, from myofascial release tools and wheelchairs to weight loss tablets and eye drops. In addition to finished products, the company also engages in global sourcing and supply chain management to assist healthcare and retail clients in procuring essential products. This integrated approach allows Medinox to serve as a comprehensive partner for businesses looking to expand their health and wellness offerings.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 1995
- Headquarters
- Carlsbad, United States
- Open positions
- None listed
- Dealroom signal
- 17.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Personal Health, Diabetes, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jan 2002 | $14M | $55M | CIH Investment Capital Limited | — |
Growth signals
Latest recorded traffic for Medinox is 400 monthly website visits, up 60% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
CIH Investment Capital Limited
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Medinox on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Medinox’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






